Patents by Inventor Steven Andrew Lantz

Steven Andrew Lantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043513
    Abstract: Pharmaceutical compositions containing anti-beta amyloid (A?) antibodies or A?-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of A? in the central nervous system, mild cognitive impairment, and A?-associated disorders such as Alzheimer's disease.
    Type: Application
    Filed: April 13, 2023
    Publication date: February 8, 2024
    Inventors: Steven Andrew Lantz, Kapil Gupta, Shantanu Sule, Adnan Zunic
  • Patent number: 11655289
    Abstract: Pharmaceutical compositions containing anti-beta amyloid (A?) antibodies or AD-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of A? in the central nervous system, mild cognitive impairment, and AD-associated disorders such as Alzheimer's disease.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: May 23, 2023
    Assignee: Biogen MA Inc.
    Inventors: Steven Andrew Lantz, Kapil Gupta, Shantanu Sule, Adnan Zunic
  • Publication number: 20210188954
    Abstract: Pharmaceutical compositions containing anti-beta amyloid (A?) antibodies or AD-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of A? in the central nervous system, mild cognitive impairment, and AD-associated disorders such as Alzheimer's disease.
    Type: Application
    Filed: August 22, 2018
    Publication date: June 24, 2021
    Inventors: Steven Andrew Lantz, Kapil Gupta, Shantanu Sule, Adnan Zunic